Failed trial: drug test for transplant complication halted early
NCT ID NCT05514119
Summary
This study tested whether fenofibrate, a cholesterol medication, could prevent bile duct damage in people who received liver transplants from deceased donors. The trial involved just 6 participants and was terminated early. Researchers wanted to see if taking the drug daily for 12 weeks would reduce complications compared to historical data.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic Arizona
Phoenix, Arizona, 85254, United States
Conditions
Explore the condition pages connected to this study.